Suppressive effect of anti-rheumatic drugs on interleukin-1β release from human peripheral blood monocytes

This publication has 21 references indexed in Scilit:

• Decrease in disease activity and concomitant increase in the percentage of peripheral blood suppressor T-cells in rheumatoid arthritis by a newly synthesized slow-acting anti-rheumatic drug (Bucillamine)
  International Journal of Immunopharmacology, 1989
• Stimulation of interleukin‐1α and interleukin‐1β release from human monocytes by cyanogen bromide peptides of type ii collagen
  Arthritis & Rheumatism, 1988
• cDNA cloning of IL-1α and IL-1β from mRNA of U937 cell line
  Biochemical and Biophysical Research Communications, 1987
• Immunopharmacological study of CCA(Lobenzarit disodium), an anti-arthritis agent — I. Abrogation of IL 1 secretion by LPS-stimulated human monocytes and induction of γ-interferon production with CCA
  International Journal of Immunopharmacology, 1986
• Sulphasalazine: a safe, effective agent for prolonged control of rheumatoid arthritis. A comparison with sodium aurothiomalate.
  Annals of the Rheumatic Diseases, 1985
• Clinical Pharmacokinetics of Sulphasalazine, Its Metabolites and Other Prodrugs of 5-Aminosalicylic Acid
  Clinical Pharmacokinetics, 1985
• An interleukin 1 like factor stimulates bone resorption in vitro
  Nature, 1983
• Effect of N-(2-carboxyphenyl)-4-chloroanthranilic acid disodium salt (CCA) on the induction of helper and suppressor T cells in vitro and in vivo.
  The Japanese Journal of Pharmacology, 1983
• Purification of a factor from human blood monocyte‐macrophages which stimulates the production of collagenase and prostaglandin E₂ by cells cultured from rheumatoid synovial tissues
  FEBS Letters, 1981
• Penicillamine Therapy for Rheumatoid Lung Disease: Effects on Protein Sulphydryl Groups
  Nature, 1966